AVBP · ArriVent BioPharma, Inc. · Analyst Estimates
Market Cap
$1.42B
Shares
49.31M
Analyst Estimates
Compare analyst forecasts for ArriVent BioPharma, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1868279
CUSIP
04272N102
13F (30d)
89 filings
89 filers
Visit website
Investor relations